Deregulated E2F activity induces hyperplasia and senescence-like features in the mouse pituitary gland.
about
Cellular senescence and tumor suppressor gene p16Old cells, new tricks: chromatin structure in senescenceCellular senescence in aging and age-related disease: from mechanisms to therapyTherapeutic targeting of replicative immortalityStem cells, senescence, neosis and self-renewal in cancer.Accumulation of senescent cells in mitotic tissue of aging primatesCEBPD suppresses prolactin expression and prolactinoma cell proliferationErasing the methyl mark: histone demethylases at the center of cellular differentiation and diseaseThe yin-yang of DNA damage response: roles in tumorigenesis and cellular senescence.Comparative analysis of E2F family member oncogenic activity.Functional identification of LRF as an oncogene that bypasses RASV12-induced senescence via upregulation of CYCLIN E.Oncogene-induced reactive oxygen species fuel hyperproliferation and DNA damage response activationSelective roles of E2Fs for ErbB2- and Myc-mediated mammary tumorigenesis.TCF7L1 promotes skin tumorigenesis independently of β-catenin through induction of LCN2.Purinergic P2Y₁₄ receptor modulates stress-induced hematopoietic stem/progenitor cell senescencep35 is required for CDK5 activation in cellular senescence.The role of senescent cells in ageing.The essence of senescence.Stable cellular senescence is associated with persistent DDR activationOncogene-triggered suppression of DNA repair leads to DNA instability in cancer.E2f binding-deficient Rb1 protein suppresses prostate tumor progression in vivoInactivation of the Rb pathway and overexpression of both isoforms of E2F3 are obligate events in bladder tumours with 6p22 amplification.Regulation of senescence in cancer and aging.What has senescence got to do with cancer?Implications of cellular senescence in tissue damage response, tumor suppression, and stem cell biology.Novel ARF/p53-independent senescence pathways in cancer repression.Cellular senescence and organismal aging.Oncogenes induce senescence with incomplete growth arrest and suppress the DNA damage response in immortalized cells.Sample-level enrichment analysis unravels shared stress phenotypes among multiple cancer typesEstradiol partially recapitulates murine pituitary cell cycle response to pregnancy.Life and death decisions by the E2F transcription factors.Cellular senescence and chromatin organisation.Assessing cell and organ senescence biomarkersSenescence in tumours: evidence from mice and humansA new p53 target gene, RKIP, is essential for DNA damage-induced cellular senescence and suppression of ERK activation.Many roads lead to oncogene-induced senescence.Oncogene-induced cellular senescence elicits an anti-Warburg effectDynamics of histone H3.3 deposition in proliferating and senescent cells reveals a DAXX-dependent targeting to PML-NBs important for pericentromeric heterochromatin organization.Interplay between oncogene-induced DNA damage response and heterochromatin in senescence and cancer.Drug-induced premature senescence model in human dental follicle stem cells.
P2860
Q24629853-E4F9CB51-4B7C-49BC-BC6A-07B2752AC869Q26750501-2EBA26FE-B7DC-4F61-8046-C69FE807EE7EQ26773500-673C0728-DFCA-49D3-8B6A-D276A004F916Q27027457-D820B143-E886-43AE-BD4C-62D3DD585223Q27497212-FBB41A10-0106-4D89-89A3-231E32DE9AD1Q28274849-A441FC37-43A5-4A10-8D29-5DB57722E861Q28564351-315E1916-F171-4811-8BE8-0252A2689004Q29617086-D1F8F25E-28D5-453B-BB1E-86C4FF6BF251Q30426400-83802F0F-A8DC-4C1A-BB61-0D4A41A471F5Q33299478-AC713E2B-A115-4357-9CD2-2D0C4EC12029Q33516747-DA826B53-766E-4E04-B611-4C0BFBF85059Q33580123-17B778FA-0EBA-4A9B-A580-780337DB4951Q33657413-9EA79D8C-6405-432B-AD8E-16E0B27AB472Q33708229-1CC45CF3-834F-4D8E-BDBB-EEDD4F3555F6Q33808171-FEB001E3-824B-43F0-8DEA-BF1CB75AA576Q33825111-0ECFA389-51A7-4F36-96DD-BEA33AA6C958Q34041036-B3587098-F9F1-4346-ACA8-EA0873C8CD93Q34288983-770A7117-0C7F-4579-86E8-C5C6B1D62428Q34395718-3AF8F49E-9530-4C7F-B9EC-504CABBA6DBFQ34483582-18E6ED69-BBEF-40DB-94CE-7DE5856CC201Q34490640-3EB79616-A439-495C-AEE7-3BB6CD37014BQ34585359-7CD752E5-FBDE-4071-9692-A394B6EA191BQ34665706-DECC1C39-26E8-49EE-9217-CD7CDDB5C9C6Q35585808-45A99DCD-90F3-4A83-B62F-EE80B2B65D96Q35773743-6B9AD71D-E0E9-49B1-A1AE-15D52B828C0BQ35810716-07F55CB8-3770-4071-8879-AB100176D127Q35815320-A1F51C05-DB5A-4FC7-A9C9-934D939D90B4Q36208555-6AA49074-999A-46FC-8607-A3F56831C493Q36245197-8568978C-5AD6-495A-8DEE-5569752584B2Q36439441-1F752D33-52A7-49F7-9221-CD88DF973715Q36499727-44DED6B1-A3F9-4CE7-9D2C-F3CC5ADFCD4EQ36609955-640765BC-2746-49B2-9366-73CEC7252205Q36776292-87F4C19B-9A8B-44CE-AB89-6D94639C814AQ36903843-CF7A6745-801F-4144-88AD-F254B6EA5FDEQ36945927-40104748-35F2-469C-B63C-50504CDBB61DQ37056216-222A00ED-F9CF-47C5-9703-1C82F8630274Q37401600-65E105E3-DF75-404C-8021-7B6DA12F5983Q37529988-F2576261-DC9A-4846-A1FF-66189FFA1146Q37569714-6A3E00B8-7F73-4D65-A855-F8067AE605A3Q37702504-22850EFB-FD3D-48DA-ACD6-94C0EC71F0FF
P2860
Deregulated E2F activity induces hyperplasia and senescence-like features in the mouse pituitary gland.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Deregulated E2F activity induc ...... in the mouse pituitary gland.
@en
Deregulated E2F activity induc ...... in the mouse pituitary gland.
@nl
type
label
Deregulated E2F activity induc ...... in the mouse pituitary gland.
@en
Deregulated E2F activity induc ...... in the mouse pituitary gland.
@nl
prefLabel
Deregulated E2F activity induc ...... in the mouse pituitary gland.
@en
Deregulated E2F activity induc ...... in the mouse pituitary gland.
@nl
P2860
P50
P1476
Deregulated E2F activity induc ...... in the mouse pituitary gland.
@en
P2093
Claire Attwooll
P2860
P304
P356
10.1128/MCB.25.7.2660-2672.2005
P407
P577
2005-04-01T00:00:00Z